The S100B protein has a strong affinity for the extracellular V-domain of the RAGE receptor. It could be used as a prognostic marker because its overexpression directly drives key pathological processes like neuroinflammation and neuronal loss, meaning its levels can predict the severity and progression of the neurological disorder.